Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
Holding GLMD?
Track your performance easily

Galmed Pharmaceuticals (GLMD) Cash flow

1,259 Followers

Galmed Pharmaceuticals Cash Flow

GLMD's free cash flow for Q4 2023 was $―. For the 2023 fiscal year, GLMD's free cash flow was decreased by $12.37M and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -9.03M$ -6.14M$ -18.50M$ -32.89M$ -26.29M$ -14.98M
Investing Cash Flow
$ 9.28M$ 800.00K$ 17.56M$ 11.46M$ 16.54M$ 6.68M
Financing Cash Flow
$ 70.00K$ 6.18M$ 70.00K$ 17.37M$ 768.00K$ 143.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 6.27M$ 2.98M$ 2.13M$ 3.00M$ 7.06M$ 16.00M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
--$ 297.00K$ 562.00K$ 1.19M-
Issuance Of Capital Stock
$ 70.00K-$ 70.00K$ 17.37M$ 707.00K-
Issuance Of Debt
-$ 6.18M----
Repayment Of Debt
------
Free Cash Flow
$ -9.03M$ -6.14M$ -18.50M$ -32.90M$ -26.33M$ -14.99M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Galmed Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis